Nov 062013
 

J&J to pay 2.2 bln dollars to settle U.S. drug probesJ&J and its subsidiaries have agreed to pay 2.2 billion to resolve criminal and civil investigations for misbranding antipsychotic drugs and paying kickbacks to pharmacists, U.S. DOJ said.

 Leave a Reply

(required)

(required)

This site uses Akismet to reduce spam. Learn how your comment data is processed.